Trump Orders Regulatory Relief for Domestic Medicine Production
Tap title to read story
0:00 / 0:33
President Trump issued an executive order aimed at boosting domestic pharmaceutical production. The order directs several agencies, including the FDA and EPA, to streamline regulations and expedite approvals for new and expanded pharmaceutical manufacturing facilities. Key goals include reducing lengthy approval times, improving inspection processes, and enhancing transparency. The initiative seeks to address vulnerabilities in the U.S. pharmaceutical supply chain and promote national security.
More context
Sources
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.
